-
1221
-
1222
Current attitudes to testicular prosthesis insertion during radical orchidectomy—An international perspective
Published 2025-01-01“…The recruitment process used social media and the emailing lists of national urological societies. Responses were collected between 10 February 2021 and 31 May 2021. …”
Get full text
Article -
1223
Bioinformatics analysis combined with experimental validation reveals the biological role of the ILK gene in prostate cancer
Published 2025-01-01“…Abstract Background Prostate cancer (PCa) is a prevalent urological malignancy. The integrin-linked kinase (ILK) gene has been identified as an oncogenic driver in hormonal cancers, including PCa. …”
Get full text
Article -
1224
-
1225
-
1226
-
1227
-
1228
-
1229
-
1230
-
1231
A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma
Published 2020-01-01Get full text
Article -
1232
Serum N-Glycan Profiling Predicts Prognosis in Patients Undergoing Hemodialysis
Published 2013-01-01Get full text
Article -
1233
-
1234
-
1235
Evaluation of three-dose fosfomycin tromethamine in the treatment of patients with urinary tract infections: an uncontrolled, open-label, multicentre study
Published 2013-12-01“…According to the diagnosis criteria of Chinese Guidelines on Urological Infections, patients (18–70 years) with acute uncomplicated cystitis, recurrent lower urinary tract infection or complicated lower urinary tract infection received three doses of 3 g fosfomycin tromethamine orally, at days 1, 3 and 5.Primary and secondary outcome measures Efficacy endpoints (clinical efficacy, microbiological efficacy and overall efficacy) were evaluated on day 15. …”
Get full text
Article -
1236
-
1237
-
1238
-
1239
-
1240